BiochemProbe — Life Science Research Reagents

GNF4877 free base · Synonyms: GNF-4877 · GNF 4877

GNF4877 is a potent DYRK1A and GSK3β inhibitor.

For research use only. Not for human or veterinary use.

Target DYRK GSK-3
Research area Metabolic Disease
Purity >98% Stock Inquire

GNF4877 structure

CAS No.: 2041073-22-5

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
100 mg USD 350.00 BP-02145-100mg In stock Get quote
250 mg USD 560.00 BP-02145-250mg In stock Get quote
500 mg USD 910.00 BP-02145-500mg In stock Get quote
1 g USD 1,460.00 BP-02145-1g In stock Get quote
2 g USD 2,250.00 BP-02145-2g In stock Get quote
3 g USD 3,400.00 BP-02145-3g In stock Get quote

Need another size or custom synthesis? Request a quote.

Description

GNF4877 is a potent DYRK1A and GSK3β inhibitor with IC50s of 6 nM and 16 nM, respectively.

Biological activity

In Vitro High glucose concentrations and glucokinase activators (GKAs) increase Ca2+ signalling in β-cells, and increase intracellular Ca2+ leads to activation of calcineurin and nuclear translocation of NFATc proteins. Indeed, concentrations of GNF4877 ((0.1 μM, 0.3 μM) well below the EC50 for β-cell proliferation are able to induce proliferation in the presence of high glucose or pharmacological activators of glucokinase. Finally, increasing intracellular Ca2+ with glibenclamide (a sulfonylurea receptor 1 inhibitor) or Bay K8644 (an L-type Ca2+ channel activator) show additive activity with GNF4877. In Vivo GNF4877 (50 mg/kg; oral gavage; twice a day; for 15 days; double transgenic RIP-DTA male mice) treatment induces β-cell proliferation, increases β-cell mass and insulin content, and improves glycaemic control.

Identifiers

SMILES
O=C([C@H]1CN(C2=C(NC(C3=NC(C4=CC(OC(C)C)=CC=C4F)=CN=C3N)=O)C=NC=C2)CCC1)O
InChIKey
UZIATSFXNVOVFE-OAHLLOKOSA-N

Specifications

MW (average)
494.5181
Formula
C25H27FN6O4
CAS No.
2041073-22-5
Physical state
Solid
Color
Light yellow to yellow
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder -20℃ 2 years; In solvent -20℃ 1 month;

Solubility

Soluble in DMSO

References

[1]. Shen W, et al. Inhibition of DYRK1A and GSK3β induces human β-cell proliferation. Nat Commun. 2015 Oct 26;6:8372.

Same target

Search DYRK

Same research area

Search Metabolic Disease

Recently viewed